A 16 yr old boy with aggressive ca esophagus DR Ayunga A.O - - PowerPoint PPT Presentation

a 16 yr old boy with aggressive
SMART_READER_LITE
LIVE PREVIEW

A 16 yr old boy with aggressive ca esophagus DR Ayunga A.O - - PowerPoint PPT Presentation

A 16 yr old boy with aggressive ca esophagus DR Ayunga A.O Physician-Garisa PGH Associate Faculty Lecturer-UON Afya Bora Fellow in Global Health Cancer of esophagus in a 16yr old Y.N 16 yr old boy unwell for the past 3 yrs with on and


slide-1
SLIDE 1

A 16 yr old boy with aggressive ca esophagus

DR Ayunga A.O Physician-Garisa PGH Associate Faculty Lecturer-UON Afya Bora Fellow in Global Health

slide-2
SLIDE 2

Cancer of esophagus in a 16yr old

  • Y.N 16 yr old boy
  • unwell for the past 3 yrs with on and off dyspepsia and

hurtburn

  • He was being managed for peptic ulcer disease.
  • Pt presented to our hospital on the 28/7/12 with c/o
  • of retrosternal and epigastric pain
  • postprandial vomiting,
  • hematemesis,
  • progressive dysphagia.
  • O/E patient was sick looking,wasted with epigastric

tenderness with no palpable masses or organomegally

slide-3
SLIDE 3

Investigations

  • Investigations done:

1.barium swallow 1yr back that demonstrated a distal 1/3 oesophageal stricture. 2.FHG which was normal. 3.h.pylori test –negative.

slide-4
SLIDE 4
  • Patient was referred to KNH for an OGD

,biopsy and CT scan which were done on 25/8/12 and showed :

  • OGD: stricture at 30cm blocking lumen.
  • Biopsy: necrotic tumor disposed in nests of

very pleomorphic squamous cells with a diagnosis of poorly differentiated SCC.

  • CT scan: malignant stricture of esophagus at

T5-T10 with proximal dilatation,small subcentimetre mediastinal nodes.

slide-5
SLIDE 5
  • Pt advised to have surgery but could not afford at

the time and presented again on 17/10/12 with vomiting,inability to swallow and hotness of body.

  • Patient was put on intravenous fluids and referred

to Nyeri for surgical management-ivor lewis esophagectomy was done on 6/11/12.

  • Tumour was resected with 3cm free margin and was

transfused 6 pints of blood.

  • Pt admitted in ICU post-op and developed ARF but

regained normal RF after 3 days of Rx.

  • Discharged while he was able to feed and with

normal bowel movements.

slide-6
SLIDE 6
  • Patient was brought back to Garissa PGH 30 days

postop for palliative management.

  • He was was markedly wasted with bilateral lower

limb pitting edema upto midleg and had a right chest tube draining purulent fluid.

  • Patient developed left sided empyema thoracis 2nd

day post admission which was drained by a chest tube.

  • right chest tube was removed but 6th post

admission day patient developed a right pneumothorax and a right chest tube was reinserted.

slide-7
SLIDE 7

Further tests after readmission

  • Investigations done:
  • FHG: WBC 12.1 with granulocytes 88%,HB 13.9,MCV

and MCH normal,PLT 207.

  • Electrolytes: k 3.59,Na 131.4,Cl 104.1.
  • Creatinine:239.52.
  • LFT:AST 41.75,ALP 346.4,GGT 181.05,Albumin

1.71,total protein 5.49,Direct bilirubin 6.56,total bilirubin 28.7.

  • Pleural fluid M/C/S: gram stain heavy growth of

s.aureus with many intracellular G-ve diplococcic sensitive to linezolid and resistant to PenG,oxacillin,azithromycin and sporfloxacin.

slide-8
SLIDE 8
  • Patient was put on high protein diet,sc heparin

5000iu BD,IV flagyl and IV ceftriaxone.

  • patient was doing well in the ward with mild

respiratory distress.

  • On 17/12/12 patient developed severe respiratory

distress with a left chest tube insitu,Xray done showed bilateral pneumothorax,patient was put on

  • xygen via nasal prongs(relatives declined via

mask).

  • family declined chest tube reinsertion on the right

side.

  • On th 18/12/12 morning patient was certified dead.
slide-9
SLIDE 9

Discussion

  • Esophageal cancer usually develops in persons

between 50 and 70 years of age.

  • M:F 3:1.
  • There are two histologic types: squamous cell

carcinoma and adenocarcinoma.

  • Chronic alcohol and tobacco use are strongly

associated with an increased risk of squamous cell carcinoma.

  • Other risks are Tylosis, achalasia, caustic-induced

esophageal stricture, and other head and neck cancers.

slide-10
SLIDE 10
  • SCC has a high incidence in certain regions of China

and Southeast Asia.

  • 50% of all cases occur in the distal third of the

esophagus.

  • Adenocarcinoma is more common in whites.
  • The majority of adenocarcinomas develop as a

complication of Barrett's metaplasia due to chronic gastroesophageal reflux.

  • Most adenocarcinomas arise in the distal third of

the esophagus

slide-11
SLIDE 11

Symptoms

  • Most pts with esophageal cancer present with

advanced, incurable disease.

  • Over 90% have solid food dysphagia, which

progresses over weeks to months.

  • Odynophagia is sometimes present.
  • Significant weight loss is common.
  • Local tumor extension into the tracheobronchial

tree may result in a TOF, characterized by coughing

  • n swallowing or pneumonia.
slide-12
SLIDE 12
  • Chest or back pain suggests mediastinal

extension.

  • Recurrent laryngeal involvement may produce

hoarseness.

  • Physical examination is often unrevealing.
  • The presence of supraclavicular or cervical

lymphadenopathy or of hepatomegaly implies metastatic disease.

slide-13
SLIDE 13

investigations

  • Lab-Non specific
  • Anaemia of chronic disease
  • Hypoalbuminemia due to malnutrion
  • CXR-may show adenopathy, a widened

mediastinum, pulmonary or bony metastases, or signs of TOF.

  • Barium esophagiogram fisrt study followed by

OGD with biopsy

slide-14
SLIDE 14

DDX

  • Achalasia
  • Peptic stricture
  • Adenocarcinoma of the gastric cardia with

esophageal extension

  • Benign tumours
slide-15
SLIDE 15

Staging

  • Done to guide therapy
  • CT scan of chest and liver to exclude

metastases,lympadenopathy or tumour extension

  • Two most important predictors of poor

survival are lymph node involvement and adjacent mediastinal spread.

slide-16
SLIDE 16

Treatment

  • Depends on the stage
  • IIIB- palliation-Combination radiation and

chemotherapy